(Q36750094)

16 August 2017

1 reference

title

Insulin lispro: a review of its use in the management of diabetes mellitus (English)

1 reference

Katherine A Lyseng-Williamson

16 August 2017

author

series ordinal

4

object named as

Katherine A Lyseng-Williamson

1 reference

16 August 2017

3

Gillian M Keating

1 reference

16 August 2017

Dene Simpson

1

1 reference

16 August 2017

Paul L McCormack

series ordinal

2

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

67

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

407-434

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767030-00006

Insulin lispro: a useful advance in insulin therapy

21 January 2018

1 reference

12 December 2020

Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

1 reference

12 December 2020

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

1 reference

12 December 2020

Effects of Rapid-Acting Insulin Analogs on Overall Glycemic Control in Type 1 and Type 2 Diabetes Mellitus

1 reference

12 December 2020

Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study

1 reference

12 December 2020

The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.

1 reference

12 December 2020

Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro

1 reference

12 December 2020

Basal-bolus insulin therapy in Type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin

1 reference

12 December 2020

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents

1 reference

12 December 2020

Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy

1 reference

12 December 2020

The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes

1 reference

12 December 2020

Standards of medical care in diabetes--2006

1 reference

12 December 2020

Optimal administration of lispro insulin in hyperglycemic type 1 diabetes

1 reference

12 December 2020

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients

1 reference

12 December 2020

Transfer of insulin lispro across the human placenta

1 reference

12 December 2020

Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus

1 reference

12 December 2020

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

1 reference

12 December 2020

Metabolic Effects of Mealtime Insulin Lispro in Comparison to Glibenclamide in Early Type 2 Diabetes

1 reference

12 December 2020

Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure

1 reference

12 December 2020

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide

1 reference

12 December 2020

Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus

1 reference

12 December 2020

Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis.

1 reference

12 December 2020

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

1 reference

12 December 2020

Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits

1 reference

12 December 2020

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal

1 reference

12 December 2020

Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus

1 reference

12 December 2020

Optimal time of administration of insulin lispro. Importance of meal composition

1 reference

12 December 2020

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

1 reference

12 December 2020

Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes

1 reference

12 December 2020

Insulin lispro lowers postprandial glucose in prepubertal children with diabetes

1 reference

12 December 2020

Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects

1 reference

12 December 2020

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus

1 reference

12 December 2020

Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin

1 reference

12 December 2020

Insulin lispro and regular insulin in pregnancy

1 reference

12 December 2020

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

1 reference

12 December 2020

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime

1 reference

12 December 2020

Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy

1 reference

12 December 2020

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.

1 reference

12 December 2020

Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Transfer of insulin lispro across the human placenta: in vitro perfusion studies

1 reference

12 December 2020

Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.

1 reference

12 December 2020

Premixed insulin analogues for the treatment of diabetes mellitus

1 reference

12 December 2020

The potential for the use of insulin lispro in pregnancy complicated by diabetes

1 reference

12 December 2020

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime

1 reference

12 December 2020

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999

1 reference

12 December 2020

Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.

1 reference

12 December 2020

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

1 reference

12 December 2020

Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin

1 reference

12 December 2020

A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus.

1 reference

12 December 2020

Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin

1 reference

12 December 2020

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

1 reference

12 December 2020

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

1 reference

12 December 2020

Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes

1 reference

12 December 2020

Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus

1 reference

12 December 2020

A desktop guide to Type 1 (insulin-dependent) diabetes mellitus. European Diabetes Policy Group 1998

1 reference

12 December 2020

Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).

1 reference

12 December 2020

Pharmacokinetic considerations of new insulin formulations and routes of administration

1 reference

12 December 2020

1 reference

12 December 2020

Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women

1 reference

12 December 2020

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Administration of Lispro insulin with meals improves glycemic control, increases circulating leptin, and suppresses ghrelin, compared with regular/NPH insulin in female patients with type 1 diabetes

1 reference

12 December 2020

Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitus

1 reference

12 December 2020

Safety of insulin lispro: pooled data from clinical trials.

1 reference

12 December 2020

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

1 reference

12 December 2020

Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care

1 reference

12 December 2020

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

1 reference

12 December 2020

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes

1 reference

12 December 2020

Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus

1 reference

12 December 2020

Is the use of insulin lispro safe in pregnancy?

1 reference

12 December 2020

Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with Type 1 diabetes

1 reference

12 December 2020

Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus

1 reference

12 December 2020

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes

1 reference

12 December 2020

Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes

1 reference

12 December 2020

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial

1 reference

12 December 2020

Insulin lispro versus regular insulin in children with type 1 diabetes on twice daily insulin.

1 reference

12 December 2020

Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes

1 reference

12 December 2020

A critical appraisal of the role of insulin analogues in the management of diabetes mellitus

1 reference

12 December 2020

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

12 December 2020

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial

1 reference

12 December 2020

Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells

1 reference

12 December 2020

Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus

1 reference

12 December 2020

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

1 reference

12 December 2020

The action profile of lispro is not blunted by mixing in the syringe with NPH insulin

1 reference

12 December 2020

Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Recombinant DNA technology in the treatment of diabetes: insulin analogs

1 reference

12 December 2020

Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group

1 reference

12 December 2020

A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes--the effect on glycaemic excursion

1 reference

12 December 2020

A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan

1 reference

12 December 2020

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

12 December 2020

10.2165/00003495-200767030-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1010103283

0 references

1 reference